Proteomic analysis of equine amniotic mesenchymal stromal cells and their extracellular vesicles: comparing their regenerative properties

Abstract

Aim: To compare specific functional features of equine amniotic mesenchymal cells (eAMCs) and their extracellular vesicles (EVs) through proteomic analysis.

Methods: eAMCs were obtained by enzymatic digestion and their EVs were isolated by ultracentrifugation. Cells and EVs were characterized according to ISCT and MISEV guidelines. A proteomic analysis of both eAMCs and EVs was conducted. The raw data files were analyzed using FragPipe 22 and uniprotkb equus_caballus_reviewed database (20.02.2025) to obtain protein identifications (false discovery rate = 0.01) and their respective label-free quantification values using recommended parameters. Statistical analysis was performed based on the combined_protein.tsv file using FragPipe-Analyst. A cutoff of the adjusted P-value of 0.05 along with a |log2 fold change| of 1 has been applied to determine differentially expressed proteins in the comparison.

Results: A total of 3,631 proteins were identified, of which 3,147 were identified with more than two peptides. Among these, 2,235 were exclusive to eAMCs, 697 were shared between eAMCs and EVs, and 71 were exclusive to EVs. eAMCs and EVs revealed distinguished proteomic profiles, differentially expressing proteins involved in biological processes related to tissue regeneration. Proteins promoting anti-inflammatory activity, oxidative stress resistance and angiogenesis exhibited increased expression levels in eAMCs, while extracellular matrix organization and deposition were predominantly upregulated in EVs.

Conclusions: Equine eAMCs and EVs are characterized by a distinct proteomic profile showing the expression of different sets of proteins involved in regenerative processes and thus different therapeutic properties. This also highlights their coordinated activity on tissue homeostasis and regeneration mechanisms.

Keywords

Amniotic mesenchymal cells / extracellular vesicles / proteomics

References

[1] Kehl D,Mallone A.Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential.NPJ Regen Med2019;4:8 PMCID:PMC6467904

[2] Al-Sharabi N,Sanz M.Proteomic analysis of mesenchymal stromal cells secretome in comparison to leukocyte- and platelet-rich fibrin.Int J Mol Sci2023;24 PMCID:PMC10487446

[3] Muntiu A,Vincenzoni F.Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization.Stem Cell Res Ther2023;14:339 PMCID:PMC10683150

[4] Lange-Consiglio A,Tassan S,Cremonesi F.Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo.Stem Cells Dev2013;22:3015-24

[5] Silini AR,Cargnoni A.Is immune modulation the mechanism underlying the beneficial effects of amniotic cells and their derivatives in regenerative medicine?.Cell Transplant2017;26:531-9 PMCID:PMC5661217

[6] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018;7:1535750 PMCID:PMC6322352

[7] Barile L,Cervio E.Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction.Cardiovasc Res2014;103:530-41

[8] Abyadeh M,Mirzaei M,Shekari F.Proteomics provides insights into the theranostic potential of extracellular vesicles.Adv Protein Chem Struct Biol2024;138:101-33

[9] Haghighitalab A,Matin MM.Extracellular vesicles and their cells of origin: open issues in autoimmune diseases.Front Immunol2023;14:1090416 PMCID:PMC10031021

[10] Crivelli B,Perteghella S.Italian Mesenchymal Stem Cell Group (GISM)Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system.J Control Release2017;262:104-17

[11] Mehryab F,Shahhosseini S.Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges.Acta Biomater2020;113:42-62

[12] Herrmann IK,Fuhrmann G.Extracellular vesicles as a next-generation drug delivery platform.Nat Nanotechnol2021;16:748-59

[13] Shekari F,Assar Kashani S,Lim R.Pre-clinical investigation of mesenchymal stromal cell-derived extracellular vesicles: a systematic review.Cytotherapy2021;23:277-84

[14] Zhang C,Zhang G.Therapeutic effect of exosomes derived from stem cells in spinal cord injury: a systematic review based on animal studies.Front Neurol2022;13:847444 PMCID:PMC8959939

[15] Lange-Consiglio A,Cantile C,Cremonesi F.Case report: use of amniotic microvesicles for regenerative medicine treatment of a mare with chronic endometritis.Front Vet Sci2020;7:347 PMCID:PMC7311574

[16] Lange-Consiglio A,Funghi F.Amniotic mesenchymal-derived extracellular vesicles and their role in the prevention of persistent post-breeding induced endometritis.Int J Mol Sci2023;24 PMCID:PMC10049450

[17] Doyle LM.Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis.Cells2019;8 PMCID:PMC6678302

[18] Lange-Consiglio A,Perrini C.MicroRNAs of equine amniotic mesenchymal cell-derived microvesicles and their involvement in anti-inflammatory processes.Cell Transplant2018;27:45-54 PMCID:PMC6434479

[19] Corrado C,Zichittella C,Conigliaro A.Molecular mediators of RNA loading into extracellular vesicles.Cells2021;10 PMCID:PMC8699260

[20] Park H,Mun D.Extracellular vesicles derived from hypoxic human mesenchymal stem cells attenuate GSK3β expression via miRNA-26a in an ischemia-reperfusion injury model.Yonsei Med J2018;59:736-45 PMCID:PMC6037597

[21] Zhu LP,Wang JY.Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction.Theranostics2018;8:6163-77 PMCID:PMC6299684

[22] Cheng H,Xu R.Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis.Stem Cell Res Ther2020;11:224 PMCID:PMC7278138

[23] Niada S,Magagnotti C,Brini AT.Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts.J Proteomics2021;232:104069

[24] Qiu G,Ge M.Functional proteins of mesenchymal stem cell-derived extracellular vesicles.Stem Cell Res Ther2019;10:359 PMCID:PMC6883709

[25] Kim HS,Yun SJ.Proteomic analysis of microvesicles derived from human mesenchymal stem cells.J Proteome Res2012;11:839-49

[26] Eirin A,Puranik AS.Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells.Sci Rep2016;6:36120 PMCID:PMC5081562

[27] Antoniadou E.Placental stem cells.Best Pract Res Clin Obstet Gynaecol2016;31:13-29

[28] Lange-Consiglio A,Bizzaro D.Characterization and potential applications of progenitor-like cells isolated from horse amniotic membrane.J Tissue Eng Regen Med2012;6:622-35

[29] Romanov YA,Smirnov VN.Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.Stem Cells2003;21:105-10

[30] Soncini M,Gibelli L.Isolation and characterization of mesenchymal cells from human fetal membranes.J Tissue Eng Regen Med2007;1:296-305

[31] Welsh JA,O’Driscoll L.MISEV ConsortiumMinimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches.J Extracell Vesicles2024;13:e12404 PMCID:PMC10850029

[32] Yu F,Nesvizhskii AI.MSFragger-DDA+ enhances peptide identification sensitivity with full isolation window search.Nat Commun2025;16:3329 PMCID:PMC11978857

[33] Hsiao Y,Li GX.Analysis and visualization of quantitative proteomics data using FragPipe-analyst.J Proteome Res2024;23:4303-15

[34] Gummadi S,Kang T,Mathivanan S.ExoCarta 2024: a web-based repository of small extracellular vesicles cargo.J Mol Biol2025;437:169218

[35] Liang X,Zhang Y,Lian Q.Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.Cell Transplant2014;23:1045-59

[36] Viswanathan S,Galipeau J.Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature.Cytotherapy2019;21:1019-24

[37] Dominici M,Mueller I.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.Cytotherapy2006;8:315-7

[38] Shin S,Kwon Y.Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and Wharton’s jelly.Int J Mol Sci2021;22 PMCID:PMC7829982

[39] Braga CL,Santos RT.Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions.Cytotherapy2022;24:1211-24

[40] Hanada T.Regulation of cytokine signaling and inflammation.Cytokine Growth Factor Rev2002;13:413-21

[41] McCormick SM.Commentary: IL-4 and IL-13 receptors and signaling.Cytokine2015;75:38-50 PMCID:PMC4546937

[42] Mathern DR.Molecules great and small: the complement system.Clin J Am Soc Nephrol2015;10:1636-50 PMCID:PMC4559511

[43] Reichhardt MP.Intracellular complement activation - an alarm raising mechanism?.Semin Immunol2018;38:54-62

[44] Levy S,Maecker HT.CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system.Annu Rev Immunol1998;16:89-109

[45] Fan Y,Cocozza F.Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles.J Extracell Vesicles2023;12:e12352 PMCID:PMC10390663

[46] Stepkowski SM,Ross JA,Kirken RA.STAT3: an important regulator of multiple cytokine functions.Transplantation2008;85:1372-7

[47] Kalinski P.Regulation of immune responses by prostaglandin E2.J Immunol2012;188:21-8 PMCID:PMC3249979

[48] Kulesza A,Burdzinska A.The Role of COX-2 and PGE2 in the regulation of immunomodulation and other functions of mesenchymal stromal cells.Biomedicines2023;11 PMCID:PMC9952951

[49] Bui TM,Sumagin R.ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis.J Leukoc Biol2020;108:787-99 PMCID:PMC7977775

[50] Wei D,Zhu L,Sun C.USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of HSP90AA1.Cell Death Dis2023;14:566 PMCID:PMC10460448

[51] Choi S,Lee HJ.Expression of Cu/Zn SOD protein is suppressed in hsp 70.1 knockout mice.J Biochem Mol Biol2005;38:111-4

[52] Johnston AD.The redox system in C. elegans, a phylogenetic approach.J Toxicol2012;2012:546915 PMCID:PMC3415087

[53] Yang HC,Liu HY,Chiu DT.What has passed is prolog: new cellular and physiological roles of G6PD.Free Radic Res2016;50:1047-64

[54] Chen PH,Yang HC,Stern A.Glucose-6-phosphate dehydrogenase, redox homeostasis and embryogenesis.Int J Mol Sci2022;23 PMCID:PMC8878822

[55] Park DJ,Ho K.Serpin-loaded extracellular vesicles promote tissue repair in a mouse model of impaired wound healing.J Nanobiotechnology2022;20:474 PMCID:PMC9636779

[56] Koga Y,Cheng E.Genome-wide screen of promoter methylation identifies novel markers in melanoma.Genome Res2009;19:1462-70 PMCID:PMC2720187

[57] Watt FM.Role of integrins in regulating epidermal adhesion, growth and differentiation.EMBO J2002;21:3919-26 PMCID:PMC126145

[58] Chou CW,Kuo TT,Sher YP.An overview of ADAM9: structure, activation, and regulation in human diseases.Int J Mol Sci2020;21 PMCID:PMC7590139

[59] Calzada MJ,Krutzsch HC.Recognition of the N-terminal modules of thrombospondin-1 and thrombospondin-2 by alpha6beta1 integrin.J Biol Chem2003;278:40679-87

[60] Bornstein P.Thrombospondins function as regulators of angiogenesis.J Cell Commun Signal2009;3:189-200 PMCID:PMC2778581

[61] Tombran-Tink J.The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling.Front Biosci2005;10:2131-49

[62] Acoba MG,Renuse S.The mitochondrial carrier SFXN1 is critical for complex III integrity and cellular metabolism.Cell Rep2021;34:108869 PMCID:PMC8048093

[63] Banerjee M,Zhang J.Cellubrevin/vesicle-associated membrane protein-3-mediated endocytosis and trafficking regulate platelet functions.Blood2017;130:2872-83 PMCID:PMC5746669

[64] Adams RH,Weiss C.Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.Genes Dev1999;13:295-306 PMCID:PMC316426